Rowe Section Flashcards

(38 cards)

1
Q

______ is a general term for organizations which utilize a variety of techniques to provide health care in a cost-effective manner.

A

Managed Care organizations.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

What are staff model MCOs

A

Employs physicians and may own clinics, hospitals, and pharmacies for exclusive use of their employees

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

What is the independent practice association model (IPA)?

A

MCO contracts with independent physicians in the preferred provider organization (PPO).
—> Financial incentive to use preferred network of providers.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

What are the goals of MCOs?

A
  1. Improve Quality of healthcare
  2. Improve Accessability of healthcare
  3. Improve healthcare outcomes
  4. Improve patient quality of life
  5. Contain Costs!!!
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

What is the triple aim?

A
  1. Quality
  2. Satisfaction
  3. Affordability
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

How are MCOs measured for quality?

A
  1. Health Plan Employer Data and Information Set (HEDIS)
  2. New York Quality Assurance Reporting Requirement (QARR)
  3. Centers for Medicare and Medicaid Services (CMS) Star Ratings
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

What services do PBMs provide?

A
  1. Claims processing
  2. Assist with covered medication lists (formularies)
  3. Review prior authorization requests
  4. Pharmacy Network Administration
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

What is the fastest growing component of healthcare?

A

Prescription drug costs
—> Growing faster than inflation.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

How does increasing prescription drug costs impact patients?

A
  1. Increased Premiums
  2. Increased copay/coinsurance costs
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

What are the drivers of drug trends?

A
  1. Better Diagnosis
  2. Guideline Changes
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

How do drug manufacturers influence prescription drug costs?

A
  1. Free to set prices for medications
  2. Price increases typically occur yearly
  3. Historically, few interventions from legislator.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

How do drug coupons affect prescription drug costs?

A

They reduce costs to patients, but add to overall costs of medications.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

How do PBMs heavily influence drug costs?

A
  1. PBMs have recently created “rebate aggressions” to move rebates outside PBM itself.
  2. Consolidation of PBM industy gave PBMs large negotiating power.
  3. Large PBMs have historically used rebates as a profit center. (so they demand high rebates)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

How do rare disease treatments influence prescription drug costs?

A
  1. More targeted medications often used for a small subset of patients.
  2. Less patients = Increased cost per treatment
  3. Mostly new drugs—> Expensive!!!!
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Why should drugs which have received accelerated FDA approvals be used cautiously?

A

Drugs may not be as effective for general use as anticipated.
—> Studies may use surrogate endpoints!!!! to get accelerated approval.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

______ is a continually updated list of medications which represent the current clinical judgement of physicians, pharmacists and other experts in the diagnosis and preservation of health.

A

Formulary
—> Lists how plan covers medications
—> Clinically cost-effective medications will be placed preferentially.

17
Q

What is the difference between open and closed formularies?

A

Open = All drugs available

Closed = Only listed drugs available

18
Q

What is a P&T committee, how often must they meet?

A

—> Comprised of physicians and pharmacists

–> Mandated by government agencies

—> Group develops the formulary (tier placement, utilization management)

—> Meet at least quarterly to review newly approved medications.

19
Q

What is the overall objective of the P&T committee?

A

Cost Effectiveness

20
Q

What are factors the P&T committee considers?

A
  1. Safety and Efficacy
  2. The need for the drug
  3. Effects on clinical outcomes
  4. Multiple products in a class
  5. Physician Acceptance
  6. Only if multiple drugs have equal efficacies will cost be considered.
21
Q

What drugs are covered on tier 1 of a formularly?

22
Q

What drugs are typically covered on tier 2 of a formulary?

A

–> Significant clinical advantages for brands

—> First Line Therapy

–> A unique therapeutic agent for its approved indication

23
Q

What drugs are typically covered on tier 3 of an insurance formulary?

A

–> Default tier for new agents and “me too” drugs

–> Non-preferred drugs where utilization management is still needed.

–> Formularies may also include specialty and preferred generic tiers.

24
Q

What are some methods to change total plan cost?

A

—> Reducing coverage
—> Increasing employee contributions
—> Shifts to incentivized benefit designs
—> Coinsurance
—> Min/max per Rx
—> High deductible plans
—-> Out-of-pocket maximums

25
What are prior authorizations?
---> Requires paperwork to be submitted by prescriber for review prior to a drug being covered. ---> Can be used to verify appropriate use. ---> Can be for safety reasons.
26
What is step therapy?
Requires that certain medications are tried prior to covering others.
27
What are quantity limitations?
Limits the quantity that is allowed to be fille?
28
What is diagnosis editing?
Use of medical claims data to automatically review claims for appropriateness in real time --> Reduces administrative burden ---> Provides cost savings by curbing inappropriate use. Ex) Helps to reduce utilization of GLP-1RAs in patients without Type II diabetes diagnosis.
29
What is a concurrent DUR?
1. Review drug history at time claim is filled. 2. Automatic edits in the system 3. Duplicative edits block similar medications 4. Safety edits to block severe contraindications 5. May require a prior authorization 6. May have a soft edit that a pharmacist may override.
30
What is a retrospective DUR?
1. Review of past claims history to identify concerns. ---> Concurrent opioids and benzo ---> High Dose opioid prescribing for indication ---> Gaps in atypical antipsychotic use ---> Gaps in HIV retroviral therapy use 2. Typically to provide education to members and prescribers.
31
How are specialty medications typically covered?
-->under medical or prescription benefit. --> Typically for clinically complex patients requiring additional care coordination. --> Require monitoring for dosing, side-effects compliance and administration. ---> Management of off-label use in light of clinical evidence.
32
Why are specialty drugs concerning in regard to prescription drug costs. for insurance plans?
---> 1% of prescriptions BUT ---> 44% of total costs ---> Fastest rising portion of Rx costs trend ----> costs trending at 20%+ 5-8% of toal cost of medical benefit (50% of cost for cancer related treatment)
33
Which specialty drugs are covered by prescription benefit?
Patient administered drugs
34
Which specialty drugs are covered by medical benefit?
Clinician Adminsitered drugs
35
Why is Hemgenix a specialty drug?
---> Gene therapy for hemophilia B ---> Costs ~ 3.5 million ---> Recieving hemlibra will make patient ineligble for other hemophilia B treatments. ---> for some hemophilia patients, the cost of blood factors can approach $1 million per year ----> Patients had a 54% reduction inbleeds the year after Hemgenix --> 94% of these patients discontinued prphylactic factor. *Basically although this drug is quite expensive, it actually reduces costs in the long-term*
36
What is the generic first policy?
Every 1% increase in generic fill rate, may save 1.5% in drug costs. ---> Maintains quality care ---> Lowers trend without cost shifting to members ---> Lowers member contribution
37
What are biosimilars?
--> A biologic drug that is nearly identical to an existing biologic drug (reference product) ---> Represents significant cost savings --->Most are not substitutable at the pharmacy (new rx needed) ---> competition also creates additional rebate opportunities.
38
_______ requires insurers have an MTM program in place for most medicare part D plans?
CMS --> These comprise of a complete annual review of medications and quarterly follow ups. ---> Members on complex drug regimens can have better outcomes if involved in an MTM program.